[ad_1] Dr Reddy’s Laboratories (DRL), plans to launch 15 to 20 products each year to maintain its market presence, CEO Erez Israeli said. Despite challenges with certain products, Israeli believes that the overall performance will stabilise. The company’s North American revenue declined by over 9%, driven primarily by a reduction in revenues from Revlimid, as […]